Explore the Use of
MRCTs in East Asia
The program is now available for the 7th
Annual Conference for Asian New Drug Development in Japan. Check out which
of the exciting sessions will most interest you, then register before March 25
to take advantage of the exclusive members’ only early-bird discount.
The conference, to be held at Nakano Sunplaza in Tokyo from April 15-16, will
provide a forum for exchange of opinions among the regulatory agencies in East
Asia, including the Pharmaceuticals and Medical Devices Agency (PMDA), about how
increasing multiregional clinical trial (MRCT) data should be utilized and
reviewed in New Drug Applications (NDA) in the region.
Constructive discussions will be held on how to overcome the hurdles still
remaining in new drug development using case studies of drugs that obtained
approvals in Japan based upon East Asia MRCTs.
|
|
UPcoming events
|
|
Who
should attend
This program will benefit the following individuals:
- Clinical development professionals
- Personnel involved in regulatory affairs
- Personnel at clinical study sites
- Personnel at CROs and SMOs
Early-bird deadline: March
25 Register
online or download
an application form and forward to: DIA Japan, Nisso 22 Building, 7F,
1-11-10 Azabudai, Minato-ku, Tokyo 106-0041 Japan Tel:
+81-3-5575-2130 Fax: +81-3-3583-1200 DIAJapan@diajapan.org
Tabletop exhibit opportunity Please contact DIA Japan
for details about tabletop exhibits. Tel: +81-3-5575-2130 Fax:
+81-3-3583-1200 Email: DIAJapan@diajapan.org
Thank
you to our media partners
|
|
|
|
|
No comments:
Post a Comment